Tempus, a Chicago-based technology company co-founded in 2015 by its CEO Eric Lefkofsky has recently received $80 million in funding from a group of investors to use clinical data to enable physicians to discover trends in the treatment of cancer and to collect molecular data from patients undergoing treatment. Tempus has acquired $210 million in investment since it was founded and is now valued at some $1.1 billion.
In 2006 Eric Lefkofsky and his wife Liz established the Lefkofsky Family Foundation (LFF) charity which supports the American Brain Tumor Association, co-founded by Liz Lefkofsky’s mother, as well as the Duke Medical Center’s Preston Robert Tisch Brain Tumor Center which cares for patients and their families while seeking a cure for brain tumors. The LFF also backs research into stomach and other malignant cancers, while assisting the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins develop a pancreatic cancer vaccine which is expected to be available soon.
Eric Lefkofsky graduated from the University of Michigan in 1991 and received his Juris Doctor in 1993 from the University of Michigan Law School. He is an adjunct professor at the University of Chicago and co-founder of Uptake Technologies, a predictive analytics platform for the world’s largest industries. Eric Lefkofsky also wrote Accelerated Disruption: Understanding the True Speed of Innovation.
In addition to these endeavors, Eric Lefkofsky is co-founder and Chairman of Groupon, a global e-commerce marketplace, and co-founder of Uptake Technologies, a leading predictive analytics platform for the very large industries and Echo Global Logistics, a technology-oriented logistics outsourcing firm.
Further, Eric Lefkofsky serves as a Trustee of Lurie Children’s Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry and World Business Chicago, and is Chairman of the Board of Trustees of Chicago’s Steppenwolf Theatre Company.